Baxter Healthcare SA
II - In-house lobbyists and trade/business/professional associations
Companies & groups
boulevard d'Angleterre 2-4
P.O. box: 1420
Braine l'Alleud 1420
(+32) 32 2 3868000
Mr Pierre Destexhe
Associate General Counsel
Mr Frederik Ulrichs
Manager Government Affairs and Public Policy, European Affairs
Baxter manufactures and markets products that save and sustain the lives of people with kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices and pharmaceuticals to create products that advance patient care worldwide.
Baxter has spun-off its biotech franchise as of July 1st 2015, named Baxalta.
One of Baxter's competitive strengths is its diverse technological expertise and commitment to scientific innovation. The company's unique combination of capabilities in medical devices and pharmaceuticals sets it apart from other companies in the healthcare industry.
• Baxter interacts with the EU Institutions on the legislation which has an impact on the healthcare industry through its participation in debates and public consultations
• Ensure equal access to treatment and innovative medicines to patients
• Apply innovative science to develop specialty therapeutics and medical products that save and sustain patients’ lives
• Improve conditions for prevention, treatment and care to address unmet needs
• Raise awareness and support the voice of patients suffering from chronic and life threatening diseases
• Support policy development aiming at improving regulatory processes for the healthcare sector and the competitiveness of research and industry
EU initiatives, policies and legislative files related to the field of healthcare policy and patient access
Legislative initiatives and policy issues in the field of healthcare policy and patient access
Legislative initiatives and policy issues in the field of healthcare policy and patient access.
100%: 1 75%: 0 50%: 0
|First name||Surname||Start Date||End Date|
Eucomed, Amcham EU
01/2014 - 12/2014
100,000 € - 199,999 €
No funding received from the EU institutions during the last closed financial year.
By its registration the organisation has signed the Transparency Register Code of Conduct.